The drugmaker aimed to move the lawsuits to federal court so it could forge a single defense strategy.
U.S. District Judge Maryellen Noreika dismissed J&J’s request, arguing that the drugmaker is partially responsible for the “bloomlet of litigation,” according to the report.
“J&J’s desire to centralize its own state law litigation does not justify the finding of an emergency” requiring immediate transfer, she added in her 11-page ruling.
J&J is facing 14,000 claims that its talc products contained traces of asbestos, which caused people’s ovarian cancer or mesothelioma.
More articles on pharmacy:
Insys execs guilty of opioid racketeering scheme
Walgreens shaking up C-suite
Generic drugmakers could thrive in a recession, Moody’s says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
